NASDAQ : ATYR
aTyr Pharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.95 USD (Nov 2, 2026, 9:01 AM EST) · Market cap 12.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
aTyr Pharma, Inc. (ATYR) reported revenue of 190.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 190.00K | 190.00K | 235.00K | 353.00K | 10.39M | |
| Cost of Revenue | 47.09M | 60.22M | 54.37M | 42.29M | 42.81M | 23.26M |
| Gross Profit | -46.90M | -60.03M | -54.14M | -41.94M | -32.42M | -23.26M |
| Selling, General & Admin | 16.96M | 17.60M | 13.78M | 12.98M | 13.98M | 10.75M |
| Operating Expenses | 16.96M | 17.60M | 13.78M | 12.98M | 13.98M | 10.75M |
| Operating Income | -63.86M | -77.63M | -67.91M | -54.92M | -46.40M | -34.02M |
| Other Non Operating Income (Expenses) | 3.05M | 3.50M | 3.89M | 4.52M | 1.06M | 238.00K |
| EBT Excluding Unusual Items | -60.81M | -74.12M | -64.02M | -50.40M | -45.34M | -33.78M |
| Pretax Income | -60.81M | -74.12M | -64.02M | -50.40M | -45.34M | -33.78M |
| Earnings From Continuing Operations | -60.81M | -74.12M | -64.02M | -50.40M | -45.34M | -33.78M |
| Minority Interest in Earnings | 5.00K | 5.00K | -1.00K | 8.00K | 5.00K | 9.00K |
| Net Income | -60.81M | -74.12M | -64.02M | -50.39M | -45.34M | -33.77M |
| Net Income to Common | -60.81M | -74.12M | -64.02M | -50.39M | -45.34M | -33.77M |
| Shares Outstanding (Basic) | 2.45M | 2.32M | 1.86M | 1.34M | 710.49K | 477.02K |
| Shares Outstanding (Diluted) | 2.45M | 2.32M | 1.86M | 1.34M | 710.49K | 477.02K |
| EPS (Basic) | -24.86 | -31.88 | -34.49 | -37.60 | -63.81 | -70.79 |
| EPS (Diluted) | -24.86 | -31.88 | -34.49 | -37.60 | -63.81 | -70.79 |
| Free Cash Flow | -54.82M | -62.06M | -69.18M | -37.44M | -43.53M | -33.27M |
| Free Cash Flow Per Share | -22.41 | -26.70 | -37.27 | -27.93 | -61.26 | -69.74 |
| Operating Margin | -33,609.47% | -40,856.32% | -28,899.57% | -15,557.79% | -446.79% | |
| Profit Margin | -32,003.68% | -39,009.47% | -27,243.83% | -14,274.50% | -436.53% | |
| Free Cash Flow Margin | -28,852.10% | -32,664.74% | -29,440.00% | -10,605.10% | -419.09% | |
| EBITDA | -63.20M | -76.96M | -67.21M | -54.33M | -46.17M | -33.54M |
| D&A For EBITDA | 661.00K | 664.00K | 708.00K | 592.00K | 232.00K | 475.00K |
| EBIT | -63.86M | -77.63M | -67.91M | -54.92M | -46.40M | -34.02M |
| Revenue as Reported | 190.00K | 190.00K | 235.00K | 353.00K | 10.39M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 16.16M | 10.74M | 11.05M | 22.54M | 9.98M | 2.34M |
| Short-Term Investments | 41.26M | 67.94M | 61.07M | 75.62M | 56.16M | 105.58M |
| Cash & Short-Term Investments | 57.42M | 78.69M | 72.12M | 98.17M | 66.15M | 107.91M |
| Other Receivables | 426.00K | 873.00K | 1.74M | 2.44M | 11.78M | 435.00K |
| Receivables | 426.00K | 873.00K | 1.74M | 2.44M | 11.78M | 435.00K |
| Prepaid Expenses | 518.00K | 677.00K | 8.09M | 2.39M | 2.95M | 5.22M |
| Total Current Assets | 58.36M | 80.24M | 81.95M | 102.99M | 80.87M | 113.57M |
| Property, Plant & Equipment | 9.78M | 10.38M | 11.86M | 14.05M | 11.56M | 1.81M |
| Other Long-Term Assets | 1.69M | 2.38M | 3.02M | 3.62M | 3.36M | 158.00K |
| Total Assets | 69.83M | 93.00M | 96.83M | 120.65M | 95.79M | 115.54M |
| Accounts Payable | 3.24M | 3.89M | 4.32M | 3.53M | 3.11M | 1.03M |
| Accrued Expenses | 6.69M | 9.79M | 9.39M | 11.56M | 9.86M | 4.00M |
| Current Portion of Leases | 1.46M | 1.47M | 1.25M | 1.33M | 894.00K | 980.00K |
| Total Current Liabilities | 11.40M | 15.15M | 14.97M | 16.42M | 13.86M | 6.01M |
| Long-Term Leases | 9.84M | 10.57M | 12.03M | 13.77M | 10.64M | 398.00K |
| Total Liabilities | 21.23M | 25.71M | 27.00M | 30.18M | 24.50M | 6.41M |
| Common Stock | 98.00K | 98.00K | 84.00K | 63.00K | 29.00K | 28.00K |
| Additional Paid-In Capital | 676.02M | 673.55M | 602.02M | 558.69M | 489.50M | 481.83M |
| Retained Earnings | -627.26M | -606.16M | -532.05M | -468.02M | -417.63M | -372.30M |
| Comprehensive Income & Other | -68.00K | -8.00K | -40.00K | -74.00K | -433.00K | -263.00K |
| Total Common Equity | 48.79M | 67.48M | 70.02M | 90.66M | 71.46M | 109.30M |
| Minority Interest | -194.00K | -192.00K | -187.00K | -188.00K | -180.00K | -175.00K |
| Shareholders' Equity | 48.59M | 67.29M | 69.83M | 90.47M | 71.28M | 109.13M |
| Total Liabilities & Equity | 69.83M | 93.00M | 96.83M | 120.65M | 95.79M | 115.54M |
| Total Debt | 11.30M | 12.03M | 13.28M | 15.10M | 11.53M | 1.38M |
| Net Cash (Debt) | 46.12M | 66.65M | 58.84M | 83.07M | 54.61M | 106.53M |
| Net Cash Per Share | 18.85 | 28.67 | 31.69 | 61.99 | 76.87 | 223.33 |
| Filing Date Shares Outstanding | 2.45M | 2.45M | 2.22M | 1.69M | 1.33M | 694.89K |
| Total Common Shares Outstanding | 2.45M | 2.45M | 2.10M | 1.58M | 737.46K | 694.83K |
| Working Capital | 46.97M | 65.09M | 66.99M | 86.58M | 67.01M | 107.56M |
| Book Value Per Share | 19.90 | 27.53 | 33.33 | 57.30 | 96.91 | 157.31 |
| Tangible Book Value | 48.79M | 67.48M | 70.02M | 90.66M | 71.46M | 109.30M |
| Tangible Book Value Per Share | 19.90 | 27.53 | 33.33 | 57.30 | 96.91 | 157.31 |
| Machinery | 3.44M | 3.74M | 4.50M | 5.00M | 5.00M | |
| Leasehold Improvements | 5.65M | 5.65M | 5.65M | 4.41M | 1.70M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -60.81M | -74.12M | -64.02M | -50.39M | -45.34M | -33.77M |
| Depreciation & Amortization | 1.58M | 1.55M | 1.54M | 2.74M | 1.70M | 1.30M |
| Loss (Gain) From Sale of Assets | -12.00K | -12.00K | -3.00K | -6.00K | -92.00K | 6.00K |
| Loss (Gain) From Sale of Investments | -1.27M | -1.85M | -2.71M | -3.17M | 533.00K | 366.00K |
| Stock-Based Compensation | 4.97M | 5.00M | 2.99M | 2.60M | 2.15M | 1.61M |
| Other Operating Activities | -53.00K | -5.00K | 1.00K | -8.00K | -5.00K | -9.00K |
| Change in Accounts Receivable | 80.00K | 863.00K | 402.00K | 9.05M | -11.92M | 1.60M |
| Change in Accounts Payable | -4.25M | -33.00K | -1.34M | 3.26M | 6.74M | 47.00K |
| Change in Other Net Operating Assets | 5.23M | 6.62M | -5.98M | 2.70M | 4.35M | -4.24M |
| Operating Cash Flow | -54.54M | -61.99M | -69.12M | -33.22M | -41.89M | -33.08M |
| Capital Expenditures | -279.00K | -77.00K | -65.00K | -4.21M | -1.64M | -192.00K |
| Sale of Property, Plant & Equipment | 12.00K | 12.00K | 7.00K | 15.00K | 179.00K | 50.00K |
| Investment in Securities | 23.15M | -4.99M | 17.29M | -15.93M | 48.71M | -91.42M |
| Investing Cash Flow | 22.88M | -5.05M | 17.23M | -20.13M | 47.24M | -91.57M |
| Long-Term Debt Repaid | -539.00K | -497.00K | -394.00K | -66.00K | ||
| Net Debt Issued (Repaid) | -562.00K | -539.00K | -497.00K | -394.00K | -66.00K | |
| Issuance of Common Stock | 29.78M | 66.55M | 40.36M | 66.62M | 5.52M | 110.03M |
| Financing Cash Flow | 29.21M | 66.01M | 39.86M | 66.23M | 5.45M | 110.03M |
| Net Cash Flow | -2.44M | -1.03M | -12.02M | 12.88M | 10.81M | -14.62M |
| Free Cash Flow | -54.82M | -62.06M | -69.18M | -37.44M | -43.53M | -33.27M |
| Free Cash Flow Margin | -28,852.10% | -32,664.74% | -29,440.00% | -10,605.10% | -419.09% | |
| Free Cash Flow Per Share | -22.41 | -26.70 | -37.27 | -27.93 | -61.26 | -69.74 |
| Levered Free Cash Flow | -31.71M | -33.80M | -44.36M | -21.18M | -27.93M | -20.32M |
| Unlevered Free Cash Flow | -31.71M | -33.80M | -44.36M | -21.18M | -27.93M | -20.32M |
| Cash Interest Paid | 71.00K | 94.00K | 137.00K | 172.00K | 54.00K | |
| Change in Working Capital | 1.06M | 7.45M | -6.92M | 15.01M | -833.00K | -2.59M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 12.11M | 76.73M | 303.87M | 82.57M | 63.53M | 207.60M |
| Enterprise Value | -34.01M | -1.30M | 251.27M | -4.53M | -5.37M | 92.68M |
| Last Close Price | 4.94 | 31.32 | 144.80 | 56.40 | 87.60 | 298.80 |
| PS Ratio | 63.76 | 403.86 | 1,293.07 | 233.91 | 6.12 | |
| PB Ratio | 0.25 | 1.14 | 4.35 | 0.91 | 0.89 | 1.90 |
| P/TBV Ratio | 0.25 | 1.14 | 4.34 | 0.91 | 0.89 | 1.90 |
| EV/Sales Ratio | 1,069.23 | |||||
| Debt / Equity Ratio | 0.23 | 0.18 | 0.19 | 0.17 | 0.16 | 0.01 |
| Net Debt / Equity Ratio | -0.95 | -0.99 | -0.84 | -0.92 | -0.77 | -0.98 |
| Net Debt / EBITDA Ratio | 0.73 | 0.87 | 0.88 | 1.53 | 1.18 | 3.18 |
| Net Debt / FCF Ratio | 0.84 | 1.07 | 0.85 | 2.22 | 1.25 | 3.20 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | |
| Quick Ratio | 5.08 | 5.25 | 4.93 | 6.13 | 5.62 | 18.02 |
| Current Ratio | 5.12 | 5.30 | 5.48 | 6.27 | 5.83 | 18.89 |
| Return on Equity (ROE) | -98.68% | -108.11% | -79.88% | -62.31% | -50.27% | -48.04% |
| Return on Assets (ROA) | -46.58% | -51.12% | -39.03% | -31.72% | -27.45% | -27.56% |
| Return on Capital Employed (ROCE) | -109.30% | -99.70% | -83.00% | -52.70% | -56.60% | -31.10% |
| Earnings Yield | -503.14% | -96.59% | -21.07% | -61.03% | -71.36% | -16.27% |
| FCF Yield | -452.53% | -80.88% | -22.77% | -45.34% | -68.51% | -16.02% |
| Buyback Yield / Dilution | -16.75% | -25.21% | -38.53% | -88.62% | -48.94% | -108.30% |